Full Press Release Details
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors.
SGMT
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
Key Takeaway: Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
Price reaction · baseline $4.51 (2024-03-22 close) · 1 other SGMT headline(s) in the window, move may be shared
day 0 close
+15.7%
day 1
+16%
day 3 · peak
+20.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+110%
120-day peak, hindsight
Typical move
5.7%
average across 12 past catalysts
Cash runway
~69 mo
Minimal dilution risk
Lead asset
TVB-2640
Phase 2 · Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease